+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888590
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Animal Blood Plasma Products & Derivatives Market is projected to reach USD 1.75 Billion in 2026. It is expected to continue growing at a CAGR of 7.99%, reaching USD 2.79 Billion by 2032.

Animal Blood Plasma Products and Derivatives: Executive Overview

Animal blood plasma products and derivatives are used across animal nutrition, bioprocessing, research, diagnostics, and selected industrial applications. The field includes plasma proteins, immunoglobulin-rich fractions, albumin-related materials, and other components separated from animal blood. Demand is shaped by traceability requirements, processing consistency, regulatory compliance, biosecurity, and the ability to demonstrate functional performance in end-use applications. Production economics also depend on reliable collection systems, cold-chain management, validated separation processes, and responsible sourcing practices.

Traceability, Functional Performance, and Compliance Are Reshaping the Market

The landscape is shifting from commodity-oriented processing toward differentiated, application-specific products. Buyers increasingly require documented origin, species identification, pathogen controls, batch consistency, and reproducible functional characteristics. At the same time, manufacturers are investing in improved fractionation, drying, stabilization, and analytical testing to reduce variability and expand use in demanding formulations. Sustainability considerations are also gaining importance, particularly around resource recovery, water and energy use, animal welfare expectations, and transparent supply-chain governance.

Artificial Intelligence Improves Quality Control and Supply-Chain Coordination

Artificial intelligence can strengthen the sector by identifying process deviations, correlating raw-material characteristics with finished-product performance, and supporting predictive maintenance for separation and drying equipment. Machine-learning tools can also assist with document review, release testing workflows, inventory planning, route optimization, and anomaly detection across collection and cold-chain networks. The strongest benefits depend on validated datasets, standardized laboratory methods, cybersecurity controls, and human oversight. AI should therefore augment quality and operational decisions rather than replace regulatory accountability or biosafety expertise.

Regional Insights: Regulation and Processing Maturity Differ Across Geographies

North America emphasizes sophisticated food, feed, biologics, and laboratory supply chains, with strong attention to quality systems, traceability, and biosecurity. Europe combines stringent animal by-product, feed, environmental, and consumer-protection requirements with interest in circular processing and documented sustainability. Asia-Pacific presents diverse conditions, ranging from advanced processing and research capabilities to rapidly formalizing collection and quality systems. Latin America benefits from substantial livestock and agricultural activity but must manage logistics, sanitary controls, and regional regulatory variation. The Middle East places importance on import compliance, food and feed safety, halal considerations where applicable, and dependable supply. Africa offers opportunities linked to livestock and local value addition, while infrastructure, testing capacity, collection formalization, and regulatory consistency remain central challenges.

Group Insights: Trade, Standards, and Regional Integration Shape Participation

ASEAN markets are influenced by expanding food, feed, biotechnology, and research networks, while differences in national standards and logistics affect cross-border coordination. BRICS participants span major livestock, manufacturing, research, and consumption centers, making sanitary equivalence and trade procedures important to collaboration. The European Union is shaped by harmonized rules, animal by-product controls, environmental obligations, and rigorous documentation. G7 economies generally combine advanced laboratory and processing capabilities with demanding quality, safety, and sustainability expectations. GCC markets prioritize secure sourcing, import reliability, and compliance with applicable food, feed, and religious requirements. NATO members represent a broad set of highly regulated economies where resilience, biosafety, and continuity of critical biological supply chains are significant considerations.

Country Insights: National Priorities Range from Production Scale to Import Assurance

Australia combines livestock resources with strong biosecurity and export-oriented quality practices. Brazil has extensive animal agriculture and processing capacity, with traceability and sanitary compliance important for domestic and international channels. Canada emphasizes regulated production, research, and cold-chain integrity. China is developing broad biotechnology, feed, and processing capabilities while maintaining close attention to safety and supply assurance. France, Germany, Italy, and Spain operate within European Union requirements and focus on quality systems, environmental controls, and specialized end uses. India combines a large livestock and research base with varied infrastructure and regulatory implementation. Japan and South Korea emphasize advanced manufacturing, analytical control, and dependable imports or domestic sourcing. Mexico links livestock processing with North American trade and sanitary requirements. Russia’s sector is influenced by domestic supply resilience, veterinary controls, and trade conditions. The United Kingdom maintains robust quality, biosecurity, and regulatory expectations after its separation from the European Union framework. The United States remains characterized by sophisticated processing, research, feed, and regulatory systems, with strong emphasis on documentation and product consistency.

Industry Priorities: Build Verified Supply, Resilient Processing, and Application-Specific Value

Leaders should establish end-to-end traceability from collection through final release, supported by supplier qualification, species controls, pathogen monitoring, and documented chain of custody. Investment should focus on validated fractionation and stabilization processes, fit-for-purpose analytical testing, and flexible production lines that can serve distinct applications without compromising segregation. Companies should also strengthen regional sourcing options, emergency inventory policies, cold-chain visibility, and regulatory intelligence. Responsible growth requires measurable resource-efficiency goals, transparent animal-derived material policies, and clear technical documentation for customers. AI deployment should begin with high-value, auditable use cases such as quality anomaly detection, maintenance planning, and demand coordination, with governance built into implementation.

Research Methodology: Evidence-Based Assessment of the Value Chain

This executive summary uses a structured assessment of the animal blood plasma products and derivatives value chain. The approach evaluates raw-material availability, collection and preservation practices, separation and formulation technologies, end-use requirements, regulatory conditions, trade and logistics factors, quality systems, sustainability considerations, and digital adoption. Regional, group, and country comparisons are interpreted through documented differences in livestock systems, industrial capability, research infrastructure, sanitary governance, and market-access conditions. Findings are framed qualitatively and exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Reliability, Compliance, and Technical Differentiation Will Define Resilience

The sector’s development depends less on raw-material access alone than on the ability to convert variable biological inputs into safe, consistent, and well-documented products. Traceability, validated processing, biosecurity, sustainability, and resilient logistics are becoming core competitive requirements across regions and end uses. Organizations that combine disciplined quality management with application-focused innovation and carefully governed digital tools will be better positioned to meet evolving customer and regulatory expectations. Continued progress will require cooperation among processors, livestock and slaughter networks, laboratories, regulators, researchers, and downstream users.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Blood Plasma Products & Derivatives Market, by Product Type
7.1. Introduction
7.2. Dried Plasma
7.3. Fresh Frozen Plasma
7.4. Plasma Powder
7.5. Plasma Concentrates
8. Animal Blood Plasma Products & Derivatives Market, by Animal Type
8.1. Introduction
8.2. Avian
8.3. Bovine
8.4. Ovine
8.5. Porcine
9. Animal Blood Plasma Products & Derivatives Market, by Derivative Type
9.1. Introduction
9.2. Fetal Bovine Serum
9.3. Fibrinogen
9.4. Immunoglobulin
9.5. Serum Albumin
9.6. Thrombin
10. Animal Blood Plasma Products & Derivatives Market, by Form
10.1. Introduction
10.2. Liquid
10.3. Powder
10.4. Frozen
10.5. Lyophilized
11. Animal Blood Plasma Products & Derivatives Market, by Application
11.1. Introduction
11.2. Animal Feed
11.3. Food Processing
11.4. Nutrition Supplements
11.5. Pharmaceuticals & Cosmetics
11.6. Tissue Engineering
12. Animal Blood Plasma Products & Derivatives Market, by End-User
12.1. Introduction
12.2. Food Manufacturers
12.3. Pharmaceutical Companies
12.4. Veterinary
13. Animal Blood Plasma Products & Derivatives Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Animal Blood Plasma Products & Derivatives Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Animal Blood Plasma Products & Derivatives Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. ACROBiosystems Inc.
17.2. ANZCO Foods Limited
17.3. Auckland BioSciences Ltd.
17.4. BioChemed Services
17.5. Biowest Company
17.6. Bovogen Biologicals Pty Ltd.
17.7. Canvax Reagents S.L.
17.8. Ebrator Biochemicals Inc.
17.9. Kraeber & Co. GmbH
17.10. Lake Immunogenics, Inc.
17.11. LAMPIRE Biological Laboratories, Inc.
17.12. Merck KGaA
17.13. Pel-Freez, LLC
17.14. Rockland Immunochemicals, Inc.
17.15. Rocky Mountain Biologicals
17.16. Scripps Laboratories, Inc.
17.17. TCS Biosciences Ltd.
17.18. Thermo Fisher Scientific Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Animal Blood Plasma Products & Derivatives Market, Years Considered for the Study
FIGURE 2. Global Animal Blood Plasma Products & Derivatives Market, Research Design
FIGURE 3. Global Animal Blood Plasma Products & Derivatives Market, Research Framework
FIGURE 4. Global Animal Blood Plasma Products & Derivatives Market, Data Triangulation
FIGURE 5. Global Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2025 vs 2032 (%)
FIGURE 11. Global Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Animal Blood Plasma Products & Derivatives Market Size, by Form, 2025 vs 2032 (%)
FIGURE 13. Global Animal Blood Plasma Products & Derivatives Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Animal Blood Plasma Products & Derivatives Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Animal Blood Plasma Products & Derivatives Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Animal Blood Plasma Products & Derivatives Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Animal Blood Plasma Products & Derivatives Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Animal Blood Plasma Products & Derivatives Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Animal Blood Plasma Products & Derivatives Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Animal Blood Plasma Products & Derivatives Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Animal Blood Plasma Products & Derivatives Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Animal Blood Plasma Products & Derivatives Market Segmentation & Coverage
TABLE 2. Global Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 3. Global Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Dried Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dried Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dried Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Fresh Frozen Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Fresh Frozen Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Fresh Frozen Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Plasma Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Plasma Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Plasma Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Plasma Concentrates Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Plasma Concentrates Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Plasma Concentrates Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 17. Global Avian Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Avian Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Avian Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Ovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Ovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Ovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 30. Global Fetal Bovine Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Fetal Bovine Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Fetal Bovine Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Fibrinogen Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Fibrinogen Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Fibrinogen Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Immunoglobulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Immunoglobulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Immunoglobulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Serum Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Serum Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Serum Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Thrombin Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Thrombin Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Thrombin Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 46. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Frozen Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Frozen Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Frozen Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 59. Global Animal Feed Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Animal Feed Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Animal Feed Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Food Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Food Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Food Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Nutrition Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Nutrition Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Nutrition Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Pharmaceuticals & Cosmetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Pharmaceuticals & Cosmetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceuticals & Cosmetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Tissue Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Tissue Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Tissue Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 75. Global Food Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Food Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Food Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Veterinary Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Veterinary Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Veterinary Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 92. North America Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. North America Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. North America Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 95. North America Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 96. North America Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 97. North America Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 99. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 102. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 103. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 104. Latin America Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Latin America Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 106. Europe Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Europe Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Europe Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 109. Europe Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 110. Europe Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 111. Europe Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Europe Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 113. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 116. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 117. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 118. Middle East Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Middle East Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 120. Africa Animal Blood Plasma Products & Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Africa Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. Africa Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 123. Africa Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 124. Africa Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 125. Africa Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Africa Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 127. Global Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 131. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 132. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 133. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. ASEAN Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 135. GCC Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. GCC Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. GCC Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 138. GCC Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 139. GCC Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 140. GCC Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. GCC Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 142. European Union Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. European Union Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. European Union Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 145. European Union Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 146. European Union Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 147. European Union Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. European Union Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 149. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 152. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 153. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 154. BRICS Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. BRICS Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 156. G7 Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. G7 Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. G7 Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 159. G7 Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 160. G7 Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 161. G7 Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. G7 Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 163. NATO Animal Blood Plasma Products & Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. NATO Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. NATO Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 166. NATO Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 167. NATO Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 168. NATO Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. NATO Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 170. Global Animal Blood Plasma Products & Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 172. United States Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. United States Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 174. United States Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 175. United States Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 176. United States Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United States Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 178. Canada Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 179. Canada Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 180. Canada Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 181. Canada Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 182. Canada Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 183. Canada Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Canada Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 185. Mexico Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 186. Mexico Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. Mexico Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 188. Mexico Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 189. Mexico Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 190. Mexico Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Mexico Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 192. Brazil Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 193. Brazil Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. Brazil Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 195. Brazil Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 196. Brazil Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 197. Brazil Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Brazil Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 199. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 200. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 202. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 203. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 204. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. United Kingdom Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 206. Germany Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 207. Germany Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. Germany Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 209. Germany Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 210. Germany Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 211. Germany Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Germany Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 213. France Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 214. France Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. France Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 216. France Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 217. France Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 218. France Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. France Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 220. Russia Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 221. Russia Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Russia Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 223. Russia Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 224. Russia Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 225. Russia Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Russia Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 227. Italy Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 228. Italy Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Italy Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 230. Italy Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 231. Italy Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 232. Italy Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Italy Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 234. Spain Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 235. Spain Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. Spain Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 237. Spain Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 238. Spain Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 239. Spain Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Spain Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 241. China Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 242. China Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. China Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 244. China Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 245. China Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 246. China Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. China Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 248. India Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 249. India Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. India Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 251. India Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 252. India Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 253. India Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. India Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 255. Japan Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 256. Japan Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. Japan Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 258. Japan Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 259. Japan Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 260. Japan Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Japan Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 262. Australia Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Australia Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 265. Australia Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 266. Australia Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 267. Australia Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Australia Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 269. South Korea Animal Blood Plasma Products & Derivatives Market Size, 2017-2032 (USD Million)
TABLE 270. South Korea Animal Blood Plasma Products & Derivatives Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. South Korea Animal Blood Plasma Products & Derivatives Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 272. South Korea Animal Blood Plasma Products & Derivatives Market Size, by Derivative Type, 2017-2032 (USD Million)
TABLE 273. South Korea Animal Blood Plasma Products & Derivatives Market Size, by Form, 2017-2032 (USD Million)
TABLE 274. South Korea Animal Blood Plasma Products & Derivatives Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. South Korea Animal Blood Plasma Products & Derivatives Market Size, by End-User, 2017-2032 (USD Million)
TABLE 276. Global Animal Blood Plasma Products & Derivatives Market Share, by Key Player, 2025
TABLE 277. Global Animal Blood Plasma Products & Derivatives Market, Key Experts

Companies Mentioned

  • ACROBiosystems Inc.
  • ANZCO Foods Limited
  • Auckland BioSciences Ltd.
  • BioChemed Services
  • Biowest Company
  • Bovogen Biologicals Pty Ltd.
  • Canvax Reagents S.L.
  • Ebrator Biochemicals Inc.
  • Kraeber & Co. GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • Merck KGaA
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc.
  • Rocky Mountain Biologicals
  • Scripps Laboratories, Inc.
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.